Booij L., Tremblay R. E., Leyton M., Seguin J. R., Vitaro F., Gravel P., Perreau-Linck E., Levesque M. L., Durand F., Diksic M., Turecki G., Benkelfat C. (2010). Brain serotonin synthesis in adult males characterized by physical aggression during childhood: a 21-year longitudinal study, PLoS One, 5(6), e11255. En savoir plus.

Brent D., Melhem N., Turecki G. (2010). Pharmacogenomics of suicidal events, Pharmacogenomics, 11(6), 793-807. En savoir plus.

Brezo J., Bureau A., Merette C., Jomphe V., Barker E. D., Vitaro F., Hebert M., Carbonneau R., Tremblay R. E., Turecki G. (2010). Differences and similarities in the serotonergic diathesis for suicide attempts and mood disorders: a 22-year longitudinal gene-environment study, Mol Psychiatry, 15(8), 831-43. En savoir plus.

Chen G. G., Fiori L. M., Moquin L., Gratton A., Mamer O., Mechawar N., Turecki G. (2010). Evidence of Altered Polyamine Concentrations in Cerebral Cortex of Suicide Completers, Neuropsychopharmacology, 34 (5 ), 376-82.

Chen G. G., Turecki G., Mamer O. A. (2010). A novel liquid-liquid extraction and stable isotope dilution NCI-GC-MS method for quantitation of agmatine in postmortem brain cortex, J Mass Spectrom, 45(5), 560-5.

Fiori L. M., Turecki G. (2010). Association of the SAT1 in/del polymorphism with suicide completion, Am J Med Genet B Neuropsychiatr Genet, 153B(3), 825-9.

Fiori L. M., Turecki G. (2010). Gene expression profiling of suicide completers, Eur Psychiatry, 24 (6 ), 356-64.

Fiori L. M., Turecki G. (2010). Genetic and epigenetic influences on expression of spermine synthase and spermine oxidase in suicide completers, Int J Neuropsychopharmacol, 1-12.

Fiori L.M., Wanner B., Jomphe V., Croteau J., Vitaro F., Tremblay R.E., Bureau A., Turecki G. (2010). Association of polyaminergic Loci with anxiety, mood disorders, and attempted suicide, PLoS One, 5(11), e15146.

Hercher C., Canetti L., Turecki G., Mechawar N. (2010). Anterior cingulate pyramidal neurons display altered dendritic branching in depressed suicides, J Psychiatr Res, 44(5), 286-93.

Labonté B., Turecki G. (2010). The epigenetics of suicide: explaining the biological effects of early life environmental adversity, Arch Suicide Res, 14(4), 291-310.

Lalovic A., Klempan T., Sequeira A., Luheshi G., Turecki G. (2010). Altered expression of lipid metabolism and immune response genes in the frontal cortex of suicide completers, J Affect Disord, 120(1-3), 24-31.

Maunakea A.K., Nagarajan R.P., Bilenky M., Ballinger T.J., D'Souza C., Fouse S.D., Johnson B.E., Hong C., Nielsen C., Zhao Y., Turecki G., Delaney A., Varhol R., Thiessen N., Shchors K., Heine V.M., Rowitch D.H., Xing X., Fiore C., Schillebeeckx M., Jones S.J., Haussler D., Marra M.A., Hirst M., Wang T., Costello J.F. (2010). Conserved role of intragenic DNA methylation in regulating alternative promoters, Nature, 466(7303), 253-257.

McGirr A., Diaconu G., Berlim M.T., Pruessner J., Sable R., Cabot S., Turecki G. (2010). Dysregulation of the sympathetic nervous system, hypothalamic-pituitary-adrenal axis and executive function in individuals at risk for suicide, J Psychiatry Neurosci, 35(6), 399-408.

Meyer R.E., Salzman C., Youngstrom E.A., Clayton P.J., Goodwin F.K., Mann J.J., Alphs L.D., Broich K., Goodman W.K., Greden J.F., Meltzer H.Y., Normand S.L., Posner K., Shaffer D., Oquendo M.A., Stanley B., Trivedi M.H., Turecki G., Beasley C.M. Jr., Beautrais A.L., Bridge J.A., Brown G.K., Revicki D.A., Ryan N.D., Sheehan D.V. (2010). Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief report, J Clin Psychiatry, 71(8), 1040-1046.

Meyer R.E., Salzman C., Youngstrom E.A., Clayton P.J., Goodwin F.K., Mann J.J., Alphs L.D., Broich K., Goodman W.K., Greden J.F., Meltzer H.Y., Normand S.L., Posner K., Shaffer D., Oquendo M.A., Stanley B., Trivedi M.H., Turecki G., Beasley C.M. Jr., Beautrais A.L., Bridge J.A., Brown G.K., Revicki D.A., Ryan N.D., Sheehan D.V. (2010). Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement, J Clin Psychiatry, 71(8), e1-e21.

Ortiz A., Cervantes P., Zlotnik G., van de Velde C., Slaney C., Garnham J., Turecki G., O'Donovan C., Alda M. (2010). Cross-prevalence of migraine and bipolar disorder, Bipolar Disord, 12(4), 397-403.

Renaud J., Berlim M., Begolli M., McGirr A., Turecki G. (2010). (Letter to the Editor) Sexual Orientation and Gender Identity in Youth Suicide Victims: an Exploratory Study, Can J Psychiat, 55(1).

Roy M., Harvey P. O., Berlim M. T., Mamdani F., Beaulieu M. M., Turecki G., Lepage M. (2010). Medial prefrontal cortex activity during memory encoding of pictures and its relation to symptomatic improvement after citalopram treatment in patients with major depression, J Psychiatry Neurosci, 35(3), 152-62.

Schulze T.G., Alda M., Adli M., Akula N., Ardau R., Bui E.T., Chillotti C., Cichon S., Czerski P., Del Zompo M., Detera-Wadleigh S.D., Grof P., Gruber O., Hashimoto R., Hauser J., Hoban R., Iwata N., Kassem L., Kato T., Kittel-Schneider S., Kliwicki S., Kelsoe J.R., Kusumi I., Laje G., Leckband S.G., Manchia M., Macqueen G., Masui T., Ozaki N., Perlis R.H., Pfennig A., Piccardi P., Richardson S., Rouleau G., Reif A., Rybakowski J.K., Sasse J., Schumacher J., Severino G., Smoller J.W., Squassina A., Turecki G., Young L.T., Yoshikawa T., Bauer M., McMahon F.J. (2010). The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment, Neuropsychobiology, 62(1), 72-78.